Tobacco Products Toxicology Study

The Food and Drug Administration is forecasting a research contract titled Tobacco Products Toxicology Study aimed at evaluating the toxicity, genotoxicity, and mutagenicity of ingredients, leachables, flavors, and metals commonly present in tobacco products under review and those recently authorized, including electric nicotine delivery systems, nicotine pouches, and waterpipe tobacco. The project will generate critical toxicological data to support regulatory decision-making, inform the development of product standards, and guide future assessments of the health risks associated with these products. The study will focus on substances prevalent in current and emerging tobacco products to provide a scientific foundation for tobacco regulation. The contract is slated for release under NAICS code 541618, indicating it involves other scientific and technical consulting services. The point of contact for program inquiries is the Ctp Acquisition Liaison at ctpacquisitions@fda.hhs.gov, while the contracting officer position is pending assignment. Although the solicitation has been posted as a forecast with no specific timeline for issuance, the opportunity is anticipated to support the FDA’s mission to protect public health through science-based evaluation of tobacco products. The performance location and set-aside details are not specified, and the contract will likely require expertise in toxicology, analytical chemistry, and regulatory science to deliver robust, reproducible results.